'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings ...

Jim Cramer, the host of Mad Money, recently highlighted a surge in merger activity, pointing out that we’ve seen a ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

Jim Cramer is steering investors toward quantum computing stocks while expressing concerns about Super Micro Computer Inc.

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

Jim Cramer is optimistic about top money-center bank stocks. These four look like outstanding ideas before their earnings ...

Jim Cramer says GameStop and quantum stocks share a common thread. He recommends approaching them with caution on the recent ...

CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...

CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.